Article metrics
PDF
Other content recommended for you
- For love and money: the need to rethink benefits in HIV cure studies
- Cure research and consent: the Mississippi Baby, Barney Clark, Baby Fae and Martin Delaney
- Why cure, why now?
- Are therapeutic motivation and having one's own doctor as researcher sources of therapeutic misconception?
- How to keep high-risk studies ethical: classifying candidate solutions
- Reconceptualising risk–benefit analyses: the case of HIV cure research
- Vedolizumab treatment across antiretroviral treatment interruption in chronic HIV infection: the HAVARTI protocol for a pilot dose-ranging clinical trial to assess safety, tolerance, immunological and virological activity
- Factors associated with attitudes towards HIV cure research among transgender women and travestis: a cross-sectional survey in São Paulo, Brazil
- Informed consent to HIV cure research
- Improving on effective antiretroviral therapy: how good will a cure have to be?